Stock BCPC BALCHEM CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Balchem Corporation

Equities

BCPC

US0576652004

Specialty Chemicals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
139.3 USD +0.55% Intraday chart for Balchem Corporation -2.94% -6.38%
Mar. 29 Balchem Corporation Announces Management Changes CI
Mar. 12 Balchem Insider Sold Shares Worth $840,985, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,269 3,727 5,460 3,924 4,796 4,493 - -
Enterprise Value (EV) 1 3,269 3,727 5,460 4,298 5,041 4,604 4,453 4,259
P/E ratio 41.5 x 44.3 x 57.3 x 37.6 x 44.4 x 35.4 x 31.2 x 28.8 x
Yield 0.51% 0.5% - - - - - -
Capitalization / Revenue 5.08 x 5.3 x 6.83 x 4.16 x 5.2 x 4.66 x 4.41 x 4.2 x
EV / Revenue 5.08 x 5.3 x 6.83 x 4.56 x 5.46 x 4.77 x 4.38 x 3.98 x
EV / EBITDA 20.4 x 21.4 x 28.8 x 21.2 x 21.8 x 18.8 x 17 x 14.4 x
EV / FCF 34 x 32 x 44.4 x 48.7 x 34.6 x 28.8 x 25.9 x 22.2 x
FCF Yield 2.94% 3.13% 2.25% 2.05% 2.89% 3.48% 3.87% 4.51%
Price to Book 4.4 x 4.52 x 6.28 x 4.22 x 4.58 x 3.85 x 3.45 x -
Nbr of stocks (in thousands) 32,169 32,351 32,382 32,135 32,241 32,267 - -
Reference price 2 101.6 115.2 168.6 122.1 148.8 139.3 139.3 139.3
Announcement Date 2/21/20 2/19/21 2/18/22 2/24/23 2/16/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 643.7 703.6 799 942.4 922.4 965.1 1,018 1,071
EBITDA 1 160 174.2 189.8 202.9 230.9 244.8 262.6 295
EBIT 1 133 111.1 127.5 145.2 159.2 183.3 199.1 214
Operating Margin 20.65% 15.8% 15.96% 15.41% 17.26% 19% 19.56% 19.98%
Earnings before Tax (EBT) 1 96.48 106.4 125.2 133.7 137.3 165.5 188 202
Net income 1 79.67 84.62 96.1 105.4 108.5 127.7 144.6 156
Net margin 12.38% 12.03% 12.03% 11.18% 11.77% 13.23% 14.21% 14.57%
EPS 2 2.450 2.600 2.940 3.250 3.350 3.932 4.463 4.830
Free Cash Flow 1 96.05 116.7 123.1 88.25 145.9 160.1 172.2 192
FCF margin 14.92% 16.58% 15.4% 9.36% 15.81% 16.59% 16.91% 17.93%
FCF Conversion (EBITDA) 60.02% 66.95% 64.83% 43.5% 63.17% 65.43% 65.56% 65.08%
FCF Conversion (Net income) 120.56% 137.87% 128.05% 83.75% 134.39% 125.43% 119.05% 123.08%
Dividend per Share 0.5200 0.5800 - - - - - -
Announcement Date 2/21/20 2/19/21 2/18/22 2/24/23 2/16/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 197.9 213.1 228.9 236.7 244.3 232.5 232.5 231.3 229.9 228.7 235.5 241.5 249.1 250.6
EBITDA 1 45.45 45.63 53.57 56.47 53.77 48.89 56.12 59.07 59.89 55.43 57.35 59.5 62.17 61.62
EBIT 1 32.51 33.82 38.34 39.92 33.62 33.3 34.41 42.84 43.61 38.34 43 45.05 47.56 47.19
Operating Margin 16.43% 15.87% 16.75% 16.87% 13.77% 14.32% 14.8% 18.52% 18.97% 16.76% 18.26% 18.66% 19.1% 18.83%
Earnings before Tax (EBT) 1 32.08 33.15 37.63 39.26 31.08 25.78 29.12 38.4 36.48 33.27 37.86 40.02 43.39 43.39
Net income 1 25.01 24.95 28.93 29.78 25.25 21.41 22.71 30.11 29.08 26.65 29.23 30.94 33.5 33.51
Net margin 12.64% 11.71% 12.64% 12.58% 10.34% 9.21% 9.77% 13.02% 12.64% 11.65% 12.41% 12.81% 13.45% 13.37%
EPS 2 0.7700 0.7600 0.8900 0.9200 0.7800 0.6600 0.7000 0.9300 0.9000 0.8200 0.9000 0.9600 1.020 1.047
Dividend per Share 2 - - - - - - - - - - 0.7800 - - -
Announcement Date 10/29/21 2/18/22 4/29/22 7/29/22 11/4/22 2/24/23 4/28/23 7/28/23 10/27/23 2/16/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 374 245 111 - -
Net Cash position 1 - - - - - - 40.3 234
Leverage (Debt/EBITDA) - - - 1.844 x 1.062 x 0.4525 x - -
Free Cash Flow 1 96 117 123 88.2 146 160 172 192
ROE (net income / shareholders' equity) 11.1% 10.8% 11.3% 11.6% 13% 11.9% 12% -
ROA (Net income/ Total Assets) 7.46% 7.29% 8.13% 7.46% 8.05% 8.4% 9.5% -
Assets 1 1,069 1,161 1,183 1,412 1,348 1,520 1,522 -
Book Value Per Share 2 23.10 25.50 26.80 29.00 32.50 36.20 40.30 -
Cash Flow per Share - - - - - - - -
Capex 1 28.4 33.8 37.4 50.3 37.9 40 34 34
Capex / Sales 4.41% 4.81% 4.69% 5.34% 4.11% 4.14% 3.34% 3.17%
Announcement Date 2/21/20 2/19/21 2/18/22 2/24/23 2/16/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Balchem Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
139.3 USD
Average target price
154.8 USD
Spread / Average Target
+11.12%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
BALCHEM CORPORATION Stock Balchem Corporation
-6.38% 4.49B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. BCPC Stock
  4. Financials Balchem Corporation